General Information of DTT (ID: TTU9LGY)

DTT Name Apolipoprotein A messenger RNA (LPA mRNA) DTT Info
Gene Name LPA

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
5 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Pelacarsen DMY757D Cardiovascular disease BA00-BE2Z Phase 3 [1]
AMG 890 DM3H0IX Cardiac fibrosis DB98.8 Phase 2 [2]
ISIS-APO(a) DMQ3C05 Coronary artery disease BA80 Phase 2 [3]
LY3819469 DMUDNNF Elevated Lipoprotein(a) 5C80.1 Phase 2 [4]
SLN360 DMVVU4V Hyperlipidemia 5C80.Z Phase 2 [5]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Lipoprotein(a) and its Significance in Cardiovascular Disease: A Review. JAMA Cardiol. 2022 Jul 1;7(7):760-769.
2 Clinical pipeline report, company report or official report of Amgen.
3 Clinical pipeline report, company report or official report of ISIS Pharmaceuticals.
4 ClinicalTrials.gov (NCT05565742) A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3819469 in Adults With Elevated Lipoprotein(a). U.S.National Institutes of Health.
5 Recent lipoprotein(a) trials. Curr Opin Lipidol. 2022 Dec 1;33(6):301-308.